MedKoo Cat#: 413621 | Name: Dexoxadrol Free Base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Dexoxadrol Free Base is a dissociative anaesthetic drug which has been found to be an NMDA antagonist and produces similar effects to PCP in animals.

Chemical Structure

Dexoxadrol Free Base
Dexoxadrol Free Base
CAS#4741-41-7 (free base)

Theoretical Analysis

MedKoo Cat#: 413621

Name: Dexoxadrol Free Base

CAS#: 4741-41-7 (free base)

Chemical Formula: C20H23NO2

Exact Mass: 309.1729

Molecular Weight: 309.41

Elemental Analysis: C, 77.64; H, 7.49; N, 4.53; O, 10.34

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Dexoxadrol Free Base; HSDB7675; HSDB-7675; HSDB 7675
IUPAC/Chemical Name
d-(+)-2,2-Diphenyl-4-(2'-piperidyl)-1,3-dioxolane
InChi Key
HGKAMARNFGKMLC-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2
SMILES Code
C1(C2NCCCC2)OC(C3=CC=CC=C3)(C4=CC=CC=C4)OC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 309.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sax M, Wünsch B. Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity. Curr Top Med Chem. 2006;6(7):723-32. doi: 10.2174/156802606776894483. PMID: 16719812. 2: Aepkers M, Wünsch B. Structure-affinity relationship studies of non- competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol. Bioorg Med Chem. 2005 Dec 15;13(24):6836-49. doi: 10.1016/j.bmc.2005.07.030. Epub 2005 Sep 19. PMID: 16169732. 3: LASAGNA L, PEARSON JW. ANALGESIC AND PSYCHOTOMIMETIC PROPERTIES OF DEXOXADROL. Proc Soc Exp Biol Med. 1965 Feb;118:352-4. doi: 10.3181/00379727-118-29840. PMID: 14270339. 4: Pechnick RN, Wong CA, George R, Thurkauf A, Jacobson AE, Rice KC. Comparison of the effects of the acute administration of dexoxadrol, levoxadrol, MK-801 and phencyclidine on body temperature in the rat. Neuropharmacology. 1989 Aug;28(8):829-35. doi: 10.1016/0028-3908(89)90175-5. PMID: 2674766. 5: Banerjee A, Schepmann D, Köhler J, Würthwein EU, Wünsch B. Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists. Bioorg Med Chem. 2010 Nov 15;18(22):7855-67. doi: 10.1016/j.bmc.2010.09.047. Epub 2010 Sep 25. PMID: 20965735. 6: Thurkauf A, Mattson MV, Richardson S, Mirsadeghi S, Ornstein PL, Harrison EA Jr, Rice KC, Jacobson AE, Monn JA. Analogues of the dioxolanes dexoxadrol and etoxadrol as potential phencyclidine-like agents. Synthesis and structure- activity relationships. J Med Chem. 1992 Apr 17;35(8):1323-9. doi: 10.1021/jm00086a001. PMID: 1349351. 7: Pilapil C, Contreras P, O'Donohue TL, Quirion R. Autoradiographic distribution of [3H]dexoxadrol (a phencyclidine-related ligand) binding sites in rat and human brain. Neurosci Lett. 1985 May 1;56(1):1-6. doi: 10.1016/0304-3940(85)90431-8. PMID: 4011043. 8: Williams MW, Williford EA Jr, Williams CS, Towne JC. Clinical analgesic activity of dexoxadrol. Arch Int Pharmacodyn Ther. 1969 Mar;178(1):26-30. PMID: 4187619. 9: Brown LW, Forist AA. Kinetics of acid-catalyzed hydrolysis of dexoxadrol. J Pharm Sci. 1973 Aug;62(8):1365-7. doi: 10.1002/jps.2600620835. PMID: 4725191. 10: Moerschbaecher JM, Brocklehurst C, Devia C, Faust WB. Effects of kappa agonists and dexoxadrol on the acquisition of conditional discriminations in monkeys. J Pharmacol Exp Ther. 1987 Nov;243(2):737-44. PMID: 2824758.